Logotype for CKD Corporation

CKD (6407) Q3 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for CKD Corporation

Q3 2024 earnings summary

15 Oct, 2026

Executive summary

  • 3Q FY2023 cumulative net sales and income declined YoY, while Automatic Machinery sales and orders improved; full-year earnings forecasts remain unchanged.

  • 3Q cumulative net sales were ¥100.3 billion, down 17% YoY; operating income was ¥9.6 billion, down 41%.

Financial highlights

  • Net sales fell ¥19.9 billion YoY to ¥100.3 billion; Components declined ¥21.3 billion to ¥88.4 billion, while Automatic Machinery rose ¥1.4 billion to ¥11.8 billion.

  • Operating income was ¥9.6 billion, down ¥6.6 billion YoY; ordinary income was ¥9.7 billion, down ¥6.5 billion, and net income was ¥6.4 billion, down ¥4.8 billion.

  • Lower sales reduced operating income by ¥6.2 billion and cost-rate changes by ¥1.1 billion; SG&A and exchange-rate fluctuations each contributed ¥0.4 billion.

Outlook and guidance

  • FY2023 full-year forecasts remain unchanged: net sales ¥132.5 billion, operating income ¥11.4 billion, ordinary income ¥11.4 billion, and net income ¥7.6 billion.

  • Forecast YoY declines: net sales 17%, operating income 46%, and net income 49%; projected operating margin is 8.6%, down 4.7 points.

  • Automatic Machinery FY sales forecast is ¥17.0 billion (+9% YoY) and segment income ¥2.0 billion; Components forecast is ¥115.5 billion (-20%) and segment income ¥14.2 billion.

  • Automatic Machinery FY orders forecast was raised to ¥20.0 billion from ¥18.0 billion; 2H forecast increased to ¥8.8 billion from ¥6.8 billion.

  • Forecast exchange rate: ¥142 per US dollar for 2H and FY.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from CKD